#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Rhabdoid tumour Infective uveitis Breast angiosarcoma metastatic Adrenocortical carcinoma Vulval cancer Gastrointestinal stromal tumour Staphylococcal infection Uveal melanoma Chronic graft versus host disease in skin Ventricular fibrillation Gaucher's disease type I Leiomyosarcoma Congenital hypotransferrinaemia Bladder cancer Spinal cord injury More trials…

    Learn about Rare Diseases

    Mucopolysaccharidosis I – Life with Disease Osteosarcoma – Life with Disease Antisynthetase syndrome – Trials in Disease CADASIL – Trials in Disease Waldenstrom’s macroglobulinaemia Factor VIII deficiency – Basic Information Hereditary hypophosphataemic rickets Angiosarcoma recurrent Stevens-Johnson syndrome Rosai-Dorfman syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Phenol, Liquefied Iti-1284 Topotecan Hydrochloride CIRTUVIVINT Siplizumab Botaretigene Sparoparvovec Taxanes Cerebrolysin Concentrate Povidone Ursodoxicoltaurine Sotrovimab Lysine Aspirin Oxytocin Bi 764532 Fludrocortisone Paclitaxel Ethambutol Hydrochloride NORELGESTROMIN Nitrogen BMS-986365 More therapies…

    Learn about Your Condition

    Intervertebral disc protrusion Papulopustular rosacea Renal cancer Cardiac failure chronic Nephroblastoma HER2 negative breast cancer Upper limb fracture Essential thrombocythaemia Endocrine disorder Medulloblastoma recurrent Acne Cancer pain Stress cardiomyopathy Lysosomal storage disorder Nervous system disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Azienda Ospedaliera di Padova

Azienda Ospedaliera di Padova

Via Nicolo' Giustiniani 2, Padua, 35128, Italy

Want to learn more about this study or check if you can participate? Contact us.

  • Comparison of Risankizumab and Vedolizumab for Treatment of Moderate to Severe Ulcerative Colitis in Adults Who Have Not Received Targeted Therapies

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Risankizumab
    • Vedolizumab
    Austria Bulgaria Croatia Czechia Estonia Finland +14

  • Study on the Effects of CAL101 for Patients with Idiopathic Pulmonary Fibrosis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Idiopathic pulmonary fibrosis
    Investigated Drugs:
    • CAL101
    • Sodium Chloride
    Denmark France Italy The Netherlands Norway Romania +1

  • Study on the 9vHPV Vaccine for Preventing Oral HPV Infections in Men Aged 20-45

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Papilloma viral infection
    Investigated Drugs:
    • Human Papillomavirus Type 11 L1 Protein – Adsorbed – In The Form Of Virus-Like Particles Produced In Yeast Cells (Saccharomyces Cerevisiae Canade 3C-5 (Strain 1895)) By Rdna
    • Human Papillomavirus Type 16 L1 Protein – Adsorbed – In The Form Of Virus-Like Particles Produced In Yeast Cells (Saccharomyces Cerevisiae Canade 3C-5 (Strain 1895)) By Rdna
    • Human Papillomavirus Type 18 L1 Protein – Adsorbed – In The Form Of Virus-Like Particles Produced In Yeast Cells (Saccharomyces Cerevisiae Canade 3C-5 (Strain 1895)) By Rdna
    Belgium Czechia France Germany Italy Spain

  • Study on the Safety and Effectiveness of Clesrovimab and Palivizumab for Preventing Severe RSV in Infants and Children at High Risk

    Not recruiting

    3 1 1
    Investigated Drugs:
    • CLESROVIMAB
    • Palivizumab
    • Sodium Chloride
    Czechia Finland France Germany Greece Hungary +3

  • Study on the Safety and Effectiveness of MK-1654 for Preventing Respiratory Syncytial Virus (RSV) in Healthy Pre-Term and Full-Term Infants

    Not recruiting

    4 1 1
    Belgium Denmark Finland France Italy Poland +1

  • Study on the Effectiveness and Safety of SAR441566 for Adults with Moderate-to-Severe Ulcerative Colitis

    Not recruiting

    2 1
    Austria Belgium Bulgaria Croatia Czechia France +6

  • Study of cannabidiol (CardiolRx) in patients with recurrent pericarditis after stopping IL-1 blocker treatment

    Not recruiting

    3 1
    Investigated Drugs:
    • Cannabidiol
    Greece Italy

  • Study on Long-Term Effects of Efanesoctocog Alfa in Preventing Joint Bleeds in Patients with Hemophilia A

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Efanesoctocog Alfa
    Croatia Czechia France Germany Ireland Italy +2

  • Study for Adults with Chronic Myeloid Leukemia Using Asciminib Alone or with Nilotinib

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Asciminib Hydrochloride
    • Nilotinib
    Italy Spain

  • Study on How Cagrilintide and Semaglutide Help People with Overweight or Obesity Reduce Weight

    Not recruiting

    3 1
    Investigated Diseases:
    • Obesity
    Belgium Bulgaria Denmark Finland France Germany +4
Previous Page
1 … 22 23 24 25 26 … 41
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!